REVB (Revelation Biosciences) Stock Price
Serving as the primary valuation tool, this Revelation Biosciences (REVB) price chart on the GURU.Markets platform demonstrates the asset's dynamics 4.30. Revelation Biosciences attracts leading immunologists through flexible management and stock option programs to stimulate the body's natural defenses. The business is currently focusing on promoting its lead drug via contract manufacturing organizations, uniting scientists to develop new methods for combating viruses.
Revelation Biosciences Inc - analytical breakdowns and key metrics (REVB)
- stock value and consensus price forecast:
- business market valuation indicators:
- book capitalization information:
- debt level and financial liquidity data:
Debt to Equity Revelation Biosciences|REVB - Long-Term Liabilities to Equity|Short-Term Debt to Capital Revelation Bio|REVB - Aggregate Debt Obligations|Debts to Book Capitalization Revelation Biosciences Inc|REVB - Company Long-Term Debts|Company Short-Term Debt Revelation Biosciences|Quick Liquidity revbiosciences.com
- financial results and valuation multiples details:
REVB - Net Income|Projected Future Earnings Revelation Biosciences|REVB - P/E Multiple|Projected Price to Earnings Revelation Biosciences, Inc.|REVB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Revelation Biosciences Inc|REVB - Operating income before deduction of amortization|Earnings per share for the last twelve months Revelation Biosciences|REVB - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months revbiosciences.com|REVB - Net earnings per share growth this year|Expected earnings per share growth for next year Revelation Biosciences
- issuer revenue and sales details:
Fundamental valuation:Revelation Biosciences
For Revelation Biosciences (REVB), the price serves as an aggregated market indicator reflecting investor expectations regarding the success of clinical trials and the resilience of supply chains amid geopolitical risks. Analyzing this price chart reveals hidden threats through local drawdowns, which signal the impact of regulatory barriers or patent disputes on the fundamental capitalization of the biopharmaceutical business.
Analysis of competing companies
Price Chart argenx SE (ARGX)|BNTX (biontech.de) - Price Performance Chart|Stock Price ABVX (Abivax)|ADMA Biologics Inc (ADMA) - Market Price|PTGX: Stock Quotes|IMVT: Price Chart|KNSA: Stock Price|GRFS (grifols.com) - Price Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex Therapeutics Inc - Quote Chart|Stock Price AUPH|BCRX (BioCryst Corp) - Price Performance Chart|Stock Price VERA (Vera Therapeutics, Inc.)|Stock Price dianthustx.com DNTH|PHVS - Price Chart|Price Performance Chart ABCL (abcellera.com)|Tourmaline Corp (TRML) - Price Chart|Stock Quotes Precigen Corp|PHAR (Pharming Group N.V.) - Stock Price|Stock Price nektar.com|Stock Quotes UPB (Upstream Bio)|ZBIO (Zenas Bio) - Price Performance Chart|Stock Price IMNM (Immunome Corp)|Market Chart Gossamer Bio Corp. (GOSS)|KALV - Price Chart|septerna.com (SEPN) - Stock Quotes|Pieris Pharmaceuticals, Inc. (PVLA) - Price Chart|Stock Quotes Savara Inc|Stock Quotes RIGL|Stock Price AnaptysBio Inc.|Price Chart Astria Therapeutics (ATXS)|engene.com - Share Price|Stock Price RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - Market Price|ACRS - Price Chart|Price Performance Chart KYTX (Kyverna Therapeutics, Inc)|TLSA: Stock Price|Market Price cabalettabio.com (CABA)|Stock Quotes VTYX|Price Chart THTX|Stock Price AVTX|ELDN - Market Price|Price Chart Agenus AGEN|climbbio.com - Price Chart|Zura Bio Limited - Stock Price|ATYR - Stock Price|ADAG (adagene.com) - Stock Quotes|IMA: Price|STTK (Shattuck Labs Inc) - Stock Price|Equillium Bio (EQ) - Market Chart|Price Chart Connect Biopharma (CNTB)|IMUX - Market Price|Price Chart Atara Bio ATRA|IFRX: Share Price|XFOR: Stock Quotes|Price Performance Chart ACET (Adicet Bio)|CELU: Stock Price|INMB (INmune Bio Inc) - Price Chart|BRNS (Barinthus Bio) - Stock Price|Kezar Life Sciences Inc (KZR) - Market Chart|Price Chart SAB Biotherapeutics (SABS)|AKTX - Market Price|Price Chart Enlivex Therapeutics Ltd. ENLV|Market Chart Q32 Bio Inc (QTTB)|GeoVax Labs Inc - Stock Price|Edesa Biotech Corp (EDSA) - Stock Quotes|IBIO: Stock Price|CARM - Market Chart|XTLB (XTL Biopharmaceuticals Ltd.) - Stock Price|Market Price Bolt Bio BOLT|Price Chart HCW Biologics Inc. (HCWB)|aptevotherapeutics.com - Share Price|Stock Price AIM (AIM ImmunoTech)|ADTX - Stock Quotes|GRI Bio - Stock Price|Market Price XORTX Therapeutics Inc|ReShape Lifesciences (HIND) - Price Chart|INDP - Market Chart|Price Chart Scinai Immunotherapeutics|CALI: Price Performance Chart|Stock Price AFMD|ALLK - Market Price|HOOKIPA Pharma - Stock Quotes|IGM Biosciences Inc. - Price Chart|iTeos Therapeutics - Stock Price|OCEA: Price Chart|TC BioPharm (TCBP) - Price Chart|Quote Chart THRD (Third Harmonic Bio Inc.)
